Medeon Biodesign Statistics
Total Valuation
Medeon Biodesign has a market cap or net worth of TWD 3.94 billion. The enterprise value is 2.53 billion.
Market Cap | 3.94B |
Enterprise Value | 2.53B |
Important Dates
The next estimated earnings date is Friday, November 1, 2024.
Earnings Date | Nov 1, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Medeon Biodesign has 92.14 million shares outstanding. The number of shares has increased by 0.06% in one year.
Shares Outstanding | 92.14M |
Shares Change (YoY) | +0.06% |
Shares Change (QoQ) | +0.03% |
Owned by Insiders (%) | 11.34% |
Owned by Institutions (%) | 3.53% |
Float | 47.37M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 18.60 |
PB Ratio | 2.05 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -3.12 |
EV / Sales | 11.93 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -2.89 |
Financial Position
The company has a current ratio of 9.21, with a Debt / Equity ratio of 9.89.
Current Ratio | 9.21 |
Quick Ratio | 8.99 |
Debt / Equity | 9.89 |
Debt / EBITDA | n/a |
Debt / FCF | -0.22 |
Interest Coverage | -143.76 |
Financial Efficiency
Return on equity (ROE) is -36.75% and return on invested capital (ROIC) is -21.43%.
Return on Equity (ROE) | -36.75% |
Return on Assets (ROA) | -20.01% |
Return on Capital (ROIC) | -21.43% |
Revenue Per Employee | 5.43M |
Profits Per Employee | -20.79M |
Employee Count | 39 |
Asset Turnover | 0.08 |
Inventory Turnover | 13.54 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.18% in the last 52 weeks. The beta is 0.71, so Medeon Biodesign's price volatility has been lower than the market average.
Beta (5Y) | 0.71 |
52-Week Price Change | -10.18% |
50-Day Moving Average | 45.28 |
200-Day Moving Average | 44.94 |
Relative Strength Index (RSI) | 39.82 |
Average Volume (20 Days) | 33,363 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medeon Biodesign had revenue of TWD 211.86 million and -810.63 million in losses. Loss per share was -8.81.
Revenue | 211.86M |
Gross Profit | 18.08M |
Operating Income | -883.43M |
Pretax Income | -864.11M |
Net Income | -810.63M |
EBITDA | -840.48M |
EBIT | -883.43M |
Loss Per Share | -8.81 |
Balance Sheet
The company has 1.64 billion in cash and 193.60 million in debt, giving a net cash position of 1.45 billion or 15.71 per share.
Cash & Cash Equivalents | 1.64B |
Total Debt | 193.60M |
Net Cash | 1.45B |
Net Cash Per Share | 15.71 |
Equity (Book Value) | 1.96B |
Book Value Per Share | 20.90 |
Working Capital | 1.54B |
Cash Flow
In the last 12 months, operating cash flow was -816.16 million and capital expenditures -57.94 million, giving a free cash flow of -874.11 million.
Operating Cash Flow | -816.16M |
Capital Expenditures | -57.94M |
Free Cash Flow | -874.11M |
FCF Per Share | -9.49 |
Margins
Gross Margin | 8.53% |
Operating Margin | -416.98% |
Pretax Margin | -407.86% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -412.58% |
Dividends & Yields
Medeon Biodesign does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.06% |
Shareholder Yield | -0.06% |
Earnings Yield | -20.58% |
FCF Yield | -22.16% |
Stock Splits
The last stock split was on August 23, 2023. It was a forward split with a ratio of 1.049992864.
Last Split Date | Aug 23, 2023 |
Split Type | Forward |
Split Ratio | 1.049992864 |